ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1913

Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

Mrinalini Dey1, Shyam Budhathoki2, Sofia Ramiro3, Kaleb Michaud4, Helen Elwell5, Sam Norton6, Maya H. Buch7, Andrew Cope1, Richard Osborne8, James Galloway9 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2Imperial College London, London, United Kingdom, 3Leiden University Medical Center, Bunde, Netherlands, 4University of Nebraska Medical Center, Omaha, NE, 5British Medical Association, London, United Kingdom, 6King's College London, London, England, United Kingdom, 7Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 8Swinburne University of Technology, Swinburne, Australia, 9Centre for Rheumatic Diseases, King's College London, London, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Education, education, patient, health behaviors, Health policy, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Healthcare Disparities in Rheumatology Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Health literacy (HL) is a key social determinant of health in inflammatory arthritis (IA), including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, as it can determine engagement in diagnostic, treatment and self-management. We aimed to conduct a systematic literature review (SLR) to i) summarise associations between HL and IA outcomes; iii) inform management in IA; ii) identify areas for further research.

Methods: This SLR was registered on PROSPERO (CRD42024511354). Inclusion criteria were adults (≥18 years) with IA; studies assessing HL or interventions targeting HL; observational and qualitative studies, randomised controlled trials; English-language articles.

A comprehensive search was performed in February 2024, with MeSH headings and keywords for HL and IA, in MEDLINE, Scopus, Cochrane Library, Health Technology Assessment and PsycINFO, with no time restriction. HL measures and outcomes were not defined, to ensure capture of all potentially relevant articles.

Data were extracted on demographics, HL assessment and relevant outcomes such as (but not limited to) disease activity, quality of life, function and healthcare utilisation. Outcomes were then grouped into core themes.

Results: Of 3087 identified articles (following de-duplication), 29 were included, comprising: 22 cross-sectional studies; two randomised controlled trials; two prospective cohort studies; one case-control study; one retrospective cohort study; one qualitative study. The total cohort comprised 16402 individuals (75% female), with a mean age of 57.5 years (SD 9.6). Ethnicity was reported in 13 studies; 66% of patients were Caucasian. 89% had rheumatoid arthritis, 4% axial spondyloarthritis, 3% psoriatic arthritis and 4% unspecified IA (Table 1).

Measures of HL included: Test of Functional Health Literacy in Adults (short and long form; n=13); Single Item Literacy Screener (n=10); Rapid Estimate of Adult Literacy in Medicine (n=6); Health Literacy Questionnaire (n=2).

Identified themes included disease activity, patient-reported outcomes (PROs), healthcare utilisation and medication history. Key findings are in Figure 1.

Meta-analysis was deemed inappropriate due to marked heterogeneity of exposure and outcome measures. Outcomes were grouped based on themes. Overall, low HL was associated with worse disease activity (across a cohort of n=816 patients); greater disability (n=6678); higher depression and anxiety (n=958); higher cognitive, emotional and physical fatigue (n=708); poorer medication adherence (n=6051); lower internet access and confidence with remote consultations (n=832); increased healthcare utilisation (n=123); decreased understanding of health information and shared decision-making.

Conclusion: This is the first SLR to comprehensively synthesise the extensive outcomes associated with HL in people with IA, including increased disease activity, worse PROs, greater healthcare utilisation and decreased access to medication and care.

Our findings may be used to inform policy and resource allocation, and improve access and quality of care in IA, particularly among those patients with lower HL.

Supporting image 1

Table 1: Demographics of included study cohorts.
axSpa: axial spondyloarthritis. AYA: adolescents and young adults. IA: inflammatory arthritis. PsA: psoriatic arthritis. RA: rheumatoid arthritis. RCT: randomised controlled trial. * denotes cohorts from the same study.

Supporting image 2

Figure 1: Key associations between health literacy (HL) and outcomes in inflammatory arthritis.
eHEALS: eHealth Literacy Scale. HELP: Health Education Literacy. HLQ: Health Literacy Questionnaire. REALM: Rapid Estimate of Adult Literacy in Medicine. RLG: Rheumatology Literacy Guide. SILS: Single Item Literacy Screener. STOFHLA: Short Test of Functional Health Literacy in Adults. TOFHLA: Test of Functional Health Literacy in Adults. DMARD: disease-modifying anti-rheumatic drug. bDMARD: biologic DMARD. csDMARD: conventional synthetic DMARD. DAS: disease activity score. DAS28: disease activity score 28- joints. HAQ: Health Assessment Questionnaire. MDHAQ: Multi-Dimensional Health Assessment Questionnaire. HAD: Hospital Anxiety and Depression scale. OR: odds ratio.


Disclosures: M. Dey: None; S. Budhathoki: None; S. Ramiro: AbbVie, 1, 2, 5, 6, Alfasigma, 1, 2, 5, Galapagos, 1, 2, 5, Lilly, 1, 2, 6, MSD, 2, 5, 6, Novartis, 1, 2, 5, 6, Pfizer, 1, 2, 5, 6, UCB, 1, 2, 5, 6; K. Michaud: None; H. Elwell: None; S. Norton: None; M. Buch: AbbVie, 2, 6, Arxx Therapeutics, 2, Boehringer Ingelheim, 6, CESAS Medical, 6, Galapagos, 2, 6, Gilead, 2, 5, 6, Medistream, 6, Pfizer, 2, 6; A. Cope: AbbVie, 6, Bristol-Myers Squibb, 2, 5, 6, GSK/Galvini, 12, Data monitoring committee, Janssen, 2, 5, UCB, 2, 5; R. Osborne: None; J. Galloway: AbbVie, 6, AstraZeneca, 5, Galapagos, 2, 6, Janssen, 2, 5, 6, Lilly, 2, 6, Pfizer, 2, 5, 6, UCB, 6; E. Nikiphorou: AbbVie, 1, 6, Alfasigma, 1, 6, Fresenius Kabi, 1, 6, Galapagos, 1, 6, Gilead, 1, 6, Lilly, 1, 5, 6, Pfizer, 1, 5, 6, UCB, 1, 6.

To cite this abstract in AMA style:

Dey M, Budhathoki S, Ramiro S, Michaud K, Elwell H, Norton S, Buch M, Cope A, Osborne R, Galloway J, Nikiphorou E. Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/health-literacy-and-disease-clinical-functional-and-management-outcomes-in-inflammatory-arthritis-a-systematic-literature-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-literacy-and-disease-clinical-functional-and-management-outcomes-in-inflammatory-arthritis-a-systematic-literature-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology